Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone (BHR-100) in Severe Traumatic Brain Injury
2010-018283-16Phase 3Completed
- Sponsor
- BHR Pharmaceuticals
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing BHR-100 with Placebo (2 arms). Primary endpoint: Glasgow Outcome Score at 6 months. Started Jun 2010; status: completed.
02
Drugs
BHR-100
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2010-018283-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018283-16.